Why You Can’t Sleep in Perimenopause: The Hormone, Cortisol, and Gut Connection No One Is Talking About
A root-cause framework for understanding why midlife sleep disruption is rarely “just stress” — and what your biology is actually asking for.
You used to be a good sleeper. Maybe not perfect — but reliable. You fell asleep without much effort, stayed asleep through the night, and woke up feeling like yourself.
Then something shifted. Maybe it happened gradually: a few rough nights became a pattern, and the pattern became your baseline. Or maybe it hit all at once — jolting awake at 2am, heart racing, mind already cataloguing tomorrow’s list before you’ve taken a single breath. You tried the usual remedies. Melatonin. Magnesium. Sleep hygiene protocols you could recite in your sleep (if only you could get there). Some things helped a little. Nothing resolved it.
At some point, you probably mentioned it to your doctor. If you’re lucky, they took it seriously. More often, women tell me they heard some version of: “You’re in perimenopause. This is normal. Try to manage your stress.”
And while that’s not entirely wrong, it is profoundly incomplete. Because what’s happening to your sleep in perimenopause is not a single-system problem. It is the convergence of at least three intersecting biological disruptions — hormonal, neuroendocrine, and gastrointestinal — that most conventional assessments never consider together.
This article is my attempt to change that. I want to give you the framework I use clinically: the physiology behind why sleep breaks down in the perimenopausal transition, why cortisol and your stress axis are almost always involved, and why your gut — yes, your gut — is one of the most underappreciated drivers of how well you sleep at night.
This is not a list of sleep tips. You don’t need more tips. You need a coherent explanation. So let’s start there.
If you wake between 1am and 4am, can’t fall back asleep despite being exhausted, feel anxious for no reason at 3am, or notice your sleep is worse in the second half of your cycle — this article was written for you.
Part One: The Hormonal Scaffold of Sleep — and What Perimenopause Does to It
Sleep Is Not Just About Melatonin
Most people’s mental model of sleep hormones begins and ends with melatonin. Melatonin is important — it’s the downstream signal that tells your brain it’s time to transition into sleep. But melatonin is the final note in a much longer piece of music. And in perimenopause, it’s the earlier instruments — estrogen, progesterone, and their relationship to sleep architecture — that go out of tune first.
Progesterone: Your Brain’s Natural Sedative
Of the two primary reproductive hormones, progesterone is the one most directly tied to sleep quality. Progesterone metabolizes in the brain into a compound called allopregnanolone, which acts as a positive allosteric modulator of GABA-A receptors — the same receptor system targeted by benzodiazepines and many sleep medications. In plain language: progesterone, through its metabolite, has a natural calming and sedating effect on the central nervous system.
In the years leading up to menopause, progesterone is often the first hormone to meaningfully decline. This typically begins in the mid-to-late thirties and accelerates through the forties. Anovulatory cycles — cycles in which ovulation doesn’t occur or is incomplete — become more frequent, and since progesterone is produced primarily by the corpus luteum after ovulation, output drops accordingly.
The result: less allopregnanolone reaching GABA-A receptors. Less natural sedation. A nervous system that’s harder to downregulate at night. More light, fragmented sleep. More awakening in the second half of the night when sleep naturally becomes lighter anyway.
Clinical note: In clinical practice, I frequently see women with progesterone levels that fall within the low-normal reference range on standard labs but who have significant sleep complaints. Reference ranges are population-based; what’s “normal” for a given lab doesn’t necessarily reflect what’s optimal for an individual’s neurological function. This is precisely why functional interpretation of lab values matters.
Estrogen: Thermoregulation, REM, and Serotonin
Estrogen’s relationship to sleep is more complex and multi-directional than progesterone’s. Estrogen plays a critical role in thermoregulation — its decline destabilizes the hypothalamic thermostat, leading to the hot flashes and night sweats that many women experience as the most immediate and obvious sleep disruptors. But the mechanism goes deeper than temperature.
Estrogen also modulates the neurotransmitter environment in ways that affect sleep architecture. It supports serotonin synthesis and serotonin receptor sensitivity — and since serotonin is a precursor to melatonin (via the serotonin-melatonin pathway in the pineal gland), declining estrogen can impair melatonin production independent of any light-exposure issues. Estrogen also affects REM sleep distribution: studies in peri and postmenopausal women consistently show reductions in REM sleep percentage, which correlates with impaired memory consolidation, increased emotional reactivity, and reduced resilience to stress.
Critically, estrogen fluctuates erratically during perimenopause — it doesn’t simply decline in a linear fashion. Estrogen can spike unpredictably and then crash, which creates a moving target for the nervous system to adapt to. These fluctuations, rather than just the absolute level of estrogen, appear to be a major driver of the sleep disruption women experience in the transition years.
The sleep disruption of perimenopause isn’t simply about “low hormones.” It’s about a destabilized hormonal environment that the brain’s sleep-regulating systems struggle to adapt to — especially under concurrent stress load.
The Sleep Architecture Shift
Sleep isn’t a single state — it’s a cycle of distinct stages with distinct biological functions. Slow-wave sleep (SWS), or deep sleep, is the stage during which physical repair and immune function are most active. Growth hormone is primarily secreted during SWS. REM sleep is when emotional memory consolidation and neurological recovery occur. Both are compromised in the perimenopausal transition.
Women in perimenopause consistently show reductions in slow-wave sleep and REM sleep, increased sleep fragmentation, and longer wake-after-sleep-onset (WASO) times. What this means clinically is that even when a woman is “getting” seven or eight hours in bed, the restorative quality of that sleep has decreased significantly. She wakes unrefreshed. The hours don’t add up to the recovery they used to.
This distinction — between sleep quantity and sleep quality — is essential, and it’s almost never addressed in standard care.
Part Two: The HPA Axis, Cortisol, and Why Your Stress Response Is Sabotaging Your Sleep
Understanding the HPA Axis
The hypothalamic-pituitary-adrenal (HPA) axis is your primary stress-response system. When the brain perceives a threat — physical, psychological, or physiological — the hypothalamus signals the pituitary gland, which signals the adrenal glands to release cortisol. Cortisol is not inherently problematic; it’s essential. It mobilizes energy, modulates inflammation, and sharpens cognitive focus in the short term.
The problem arises when the HPA axis is chronically activated — when the demands on the stress response system consistently exceed its capacity to return to baseline. This is the state I see in the majority of perimenopausal women I work with, and it is both a cause and a consequence of poor sleep.
Cortisol Has a Rhythm — and Disrupted Sleep Destroys It
Under healthy conditions, cortisol follows a precise diurnal pattern. It reaches its highest level in the 30-45 minutes after waking — a phenomenon called the cortisol awakening response (CAR) — then gradually declines across the day, reaching its nadir in the late evening to allow melatonin to rise and sleep to initiate. This rhythm is essential not just for energy and stress regulation, but for virtually every other hormonal system in the body.
Poor sleep disrupts the CAR. When sleep is fragmented, insufficient, or poorly timed, the cortisol awakening response is blunted — producing a flatter, less robust morning cortisol peak. This matters because a well-defined morning cortisol peak is one of the primary anchors of circadian rhythm. When it’s blunted, the rest of the diurnal cortisol curve flattens or distorts: levels may be too low in the morning (fatigue, brain fog, poor stress tolerance) and paradoxically too high in the evening (wired but tired, sleep-onset difficulty, anxiety at bedtime).
Clinical note: A salivary cortisol curve is one of the most clinically informative tests I run in practice. A standard AM serum cortisol tells you almost nothing about cortisol dynamics across the day. A four-point salivary curve — morning, midday, evening, and bedtime — gives you a functional picture of HPA axis tone that directly informs both the clinical assessment and the intervention plan.
The Cortisol-Progesterone Seesaw
There is a critically underappreciated relationship between cortisol and progesterone that is central to understanding sleep disruption in perimenopausal women. Cortisol and progesterone compete for the same receptor — the glucocorticoid receptor — in certain tissues. Elevated cortisol can functionally antagonize progesterone’s effects, reducing its sedating, calming, and GABA-modulating activity even when progesterone levels appear adequate.
This means a woman whose progesterone is already declining due to the perimenopausal transition, and who also carries a significant chronic stress burden, faces a compounded problem: lower progesterone output plus reduced progesterone receptor sensitivity due to cortisol competition. The net neurological effect is a nervous system with significantly diminished capacity for downregulation — a recipe for the kind of hypervigilant, fragmented sleep that so many of my clients describe.
Nocturnal Cortisol and Blood Sugar: The 3am Wake-Up
One of the most common patterns I see clinically is waking between 1am and 4am, often with a racing heart, a sense of anxiety, or an inability to return to sleep despite having no obvious reason to be awake. This pattern has a specific physiological explanation that rarely gets communicated to women.
During sleep, blood glucose naturally declines as the body’s fasting state extends. Under normal conditions, the liver manages this through glycogenolysis — breaking down stored glycogen to maintain adequate glucose between meals. When blood sugar regulation is suboptimal — due to insulin resistance, poor glycemic balance from the prior day’s diet, or compromised liver glycogen stores — glucose can drop to a level that triggers a counter-regulatory stress response.
The primary counter-regulatory hormone is cortisol. When blood sugar drops in the middle of the night, cortisol (and to a lesser degree adrenaline/epinephrine) is released to mobilize glucose stores and restore balance. This nocturnal cortisol spike is precisely what wakes you up. The racing heart, the anxiety, the inability to get back to sleep — these are not psychological events. They are physiological ones, driven by a blood sugar and cortisol dynamic that a standard 8am fasting glucose will never capture.
If you consistently wake between 1am and 4am feeling anxious, wired, or with your heart racing, blood sugar dysregulation and nocturnal cortisol elevation deserve serious investigation — not just a conversation about “stress management.”
This pattern is worsened by: skipping dinner or eating a dinner very low in complex carbohydrates, having a high-carbohydrate dinner that produces a large glucose spike followed by a rapid decline, alcohol consumption in the evening (which impairs gluconeogenesis and disrupts sleep architecture in the second half of the night), and high chronic stress load that already sensitizes the HPA axis toward cortisol reactivity.
The Cortisol Awakening Response as a Clinical Window
The cortisol awakening response (CAR) deserves its own focused attention. The CAR is a discrete biological event: within the first 30-45 minutes of waking, cortisol rises sharply — by approximately 50-100% above baseline in healthy individuals — before beginning its gradual daily decline. This morning spike serves multiple functions: it consolidates waking, mobilizes energy for the day ahead, primes immune function, and anchors the circadian clock.
Research has established robust associations between a healthy, well-defined CAR and psychological resilience, immune competence, and metabolic health. Conversely, a blunted or absent CAR is associated with chronic fatigue states, burnout, immune dysregulation, and — critically — poor sleep quality the following night. The CAR and the sleep cycle are locked in a bidirectional relationship: each shapes the quality of the other.
In practice, I use the CAR as one marker of HPA axis recovery in women working to restore sleep. As sleep quality improves, the CAR typically becomes more robust. As the CAR strengthens, sleep quality in turn improves. Tracking this over a period of weeks gives both me and the client a measurable, tangible signal of physiological progress that doesn’t rely on subjective reporting alone.
Part Three: The Gut-Brain-Sleep Axis — Why Your Microbiome Is a Sleep Organ
The Enteric Nervous System and Its Connection to Sleep
The gastrointestinal tract is home to the enteric nervous system — a network of approximately 500 million neurons embedded in the gut wall, often called the “second brain.” This system communicates bidirectionally with the central nervous system via the vagus nerve, through circulating neurotransmitters and metabolites, and through immune signaling pathways. What happens in the gut does not stay in the gut — and nowhere is this more relevant than in the neurobiology of sleep.
The Gut as a Serotonin and Melatonin Factory
Approximately 90-95% of the body’s total serotonin is produced in the gastrointestinal tract, primarily by enterochromaffin cells in the intestinal lining. While gut-derived serotonin does not cross the blood-brain barrier — and so does not directly contribute to central serotonin levels — it plays a critical role in gut motility, intestinal immune function, and, through complex feedback mechanisms, influences vagal signaling to the brain in ways that affect mood and arousal states.
More directly relevant to sleep: the gut microbiome produces significant quantities of melatonin — potentially in concentrations that rival or exceed pineal gland output — as well as the precursors and co-factors required for melatonin synthesis, including tryptophan, 5-HTP, and B-vitamins (particularly B6, folate, and B12). A microbiome that is dysbiotic, depleted in diversity, or compromised in its metabolic function will produce less of these sleep-supporting compounds. The enteric production of melatonin also appears to have local gastrointestinal functions — including modulating gut motility and reducing intestinal inflammation — which creates a bidirectional link: poor gut health impairs sleep, and poor sleep impairs gut health.
Clinical note: I routinely ask clients about their bowel habits, bloating patterns, and stool characteristics as part of a sleep assessment. The gut-sleep connection is not theoretical — it is clinically observable. Clients with significant dysbiosis or gut barrier compromise almost invariably have measurable sleep architecture disruption, and addressing gut health is often one of the most impactful levers for restoring sleep quality.
Short-Chain Fatty Acids and the Sleep-Supportive Microbiome
The gut microbiome’s influence on sleep extends beyond serotonin and melatonin precursors. Specific strains of bacteria — particularly in the Firmicutes and Bifidobacterium families — produce short-chain fatty acids (SCFAs), primarily butyrate, propionate, and acetate, through the fermentation of dietary fiber. Butyrate in particular has emerged as a compound with significant sleep-regulatory effects.
Research in both animal models and human populations has shown that butyrate promotes slow-wave (deep) sleep, the most physically restorative sleep stage. The proposed mechanisms include butyrate’s role as an HDAC inhibitor (affecting gene expression in neurons involved in sleep regulation), its anti-inflammatory effects on the gut-brain axis, and its capacity to support intestinal barrier integrity — which in turn reduces the systemic inflammatory signaling that can disrupt sleep.
The practical implication: dietary fiber diversity, prebiotic intake, and microbiome composition are not just digestive considerations. They are sleep considerations. A low-fiber, high-processed-food dietary pattern depresses SCFA production, drives dysbiosis, and silently undermines sleep quality in ways that no amount of melatonin supplementation can adequately compensate for.
Gut Permeability, Systemic Inflammation, and Sleep
When the intestinal barrier is compromised — a state commonly referred to as increased intestinal permeability or “leaky gut” — bacterial components such as lipopolysaccharide (LPS) can translocate from the gut lumen into systemic circulation. LPS is a potent activator of the innate immune system and drives the production of pro-inflammatory cytokines including IL-6, TNF-alpha, and IL-1-beta.
These cytokines are not neutral from a sleep perspective. Acute elevation of inflammatory cytokines — the kind you experience with a cold or flu — initially promotes sleep as part of the immune response. But chronically elevated, low-grade inflammatory cytokines — the kind associated with gut permeability, dysbiosis, and metabolic dysfunction — disrupt sleep architecture, suppress slow-wave sleep, and increase nighttime cortisol reactivity. They essentially create a neuroimmune state of chronic low-level activation that the brain’s sleep systems cannot override.
Gut permeability, chronic inflammation, and HPA axis dysregulation form a self-reinforcing triangle. Each disrupts the others. And sleep disruption sits at the center of all three, simultaneously a consequence and an accelerant of the cycle.
The Gut-Hormone Connection: A Closing the Loop
The gut microbiome also directly participates in estrogen metabolism through a collection of microorganisms collectively called the estrobolome. Specific bacterial species produce the enzyme beta-glucuronidase, which deconjugates estrogen metabolites in the gut, allowing them to be reabsorbed into circulation rather than excreted. When the estrobolome is dysbiotic — either over-expressing or under-expressing beta-glucuronidase activity — estrogen metabolism is disrupted.
Excess beta-glucuronidase activity recirculates too much estrogen, potentially contributing to estrogen dominance. Deficient activity allows too much estrogen to be excreted, worsening the relative estrogen insufficiency that characterizes the later stages of perimenopause. Either way, the already-unstable hormonal environment of the perimenopausal transition is made more volatile by a compromised gut microbiome.
This is the closing piece of the three-system framework: the gut doesn’t just affect sleep through neurotransmitters and inflammation. It affects sleep by modulating the hormonal environment itself. Gut health, hormone balance, and stress physiology are not separate problems with separate solutions. They are one integrated system — and sleep is the readout of how well that system is functioning.
Part Four: The Functional Medicine Approach — What Assessment and Intervention Actually Look Like
Why Standard Testing Misses the Picture
Standard medical evaluation of sleep complaints typically involves a brief symptom review, perhaps a sleep hygiene checklist, and — if you’re fortunate — a referral for polysomnography to rule out obstructive sleep apnea. This is appropriate as far as it goes, but it leaves an enormous amount of actionable biology unexamined.
From a functional medicine perspective, the assessment of sleep disruption in a perimenopausal woman ideally includes the following:
A comprehensive hormone panel including estradiol, progesterone (ideally timed to luteal phase), DHEA-S, testosterone, and thyroid function including T3
A diurnal cortisol curve (four-point salivary) to assess HPA axis tone, timing, and the cortisol awakening response
Fasting insulin and glucose, hemoglobin A1c, and ideally a continuous glucose monitor trial to assess nocturnal glucose dynamics
Organic acids testing (OAT) to evaluate neurotransmitter metabolism, mitochondrial function, and nutritional cofactor status
A comprehensive stool analysis to assess microbiome diversity, dysbiosis markers, inflammatory markers, and intestinal permeability indicators
Nutritional markers including magnesium (RBC, not serum), B6, B12, folate, vitamin D, and iron/ferritin — all of which directly affect sleep physiology
This panel tells a story that a standard CBC and metabolic panel cannot. It gives us the data to build a targeted, personalized intervention rather than cycling through generic recommendations.
The Intervention Framework: Sequencing Matters
Once we have the data, the intervention is sequenced — because throwing everything at the wall simultaneously is neither sustainable nor scientifically sound. The general sequence I use clinically follows this logic:
1. Stabilize blood sugar first. Nocturnal glucose dysregulation is one of the most immediate and correctable drivers of middle-of-the-night waking. This is addressed through dinner composition (balancing protein, fat, fiber, and modest complex carbohydrate), meal timing, and in some cases a small protein-fat snack before bed to extend gluconeogenesis capacity overnight.
2. Reduce the neuroendocrine stress burden. This is not simply “do yoga.” It involves targeted interventions for HPA axis support: adaptogenic botanicals (where appropriate and evidence-supported), phosphatidylserine for evening cortisol, specific magnesium forms (glycinate, threonate) for GABA support, and structured stress-response practices timed to biological windows of maximum effect.
3. Address gut health in parallel. This involves removing dietary drivers of dysbiosis and inflammation, restoring microbial diversity through targeted prebiotic and probiotic strategies, supporting intestinal barrier integrity with mucosal nutrients, and addressing any structural issues (SIBO, dysbiosis, candida overgrowth) identified on testing.
4. Support hormone balance through lifestyle and nutrition. Dietary phytoestrogens, DIM and calcium-d-glucarate for estrogen metabolism support, seed cycling protocols for progesterone support, and targeted nutritional support for the serotonin-melatonin pathway (tryptophan, B6, zinc, magnesium). These interventions work within the hormonal milieu; they don’t override it.
5. Optimize sleep architecture directly. Circadian rhythm anchoring through consistent wake times and morning light exposure, targeted use of melatonin (low-dose, timed appropriately — not the 5-10mg doses commonly sold over the counter), and sleep environment optimization. These are support measures, not primary interventions — but they matter, and they’re more effective when the upstream biology has been addressed.
Clinical note: The sequencing matters as much as the individual interventions. Addressing circadian light exposure while ignoring nocturnal hypoglycemia will produce limited results. Working on microbiome diversity while cortisol remains chronically elevated will be partially undermined. The power of the functional medicine approach is not in any single intervention — it’s in the coherent, sequenced strategy that treats the system rather than the symptom.
What Clients Actually Experience
In my practice, women who work through this framework — with testing, a structured program, and consistent implementation support — consistently report the following progression:
Within 2–4 weeks: reduction in the frequency of nighttime waking, particularly the 1–4am cortisol-driven pattern
Within 4–8 weeks: improved sleep onset, reduced anxiety at bedtime, more consistent energy on waking
Within 8–12 weeks: measurable improvement in sleep architecture (clients using wearables report increased deep and REM sleep percentages), reduction in hot flash frequency and severity, improved mood resilience and stress tolerance
Beyond 12 weeks: most clients describe their relationship with sleep as fundamentally shifted — not because nothing ever disrupts it, but because the underlying biology is stable enough to recover quickly when life gets complicated
This is not a linear process, and I always prepare clients for that. There are weeks where progress stalls or symptoms temporarily worsen — often predictably, around the late luteal phase of the cycle, or during periods of acute life stress. What changes is the trajectory and the resilience: the return to baseline becomes faster, more reliable, less dependent on external conditions being perfect.
Part Five: What You Can Do Right Now — Before Testing, Before a Program
This article is not meant to leave you with nothing actionable. While a thorough functional medicine assessment and personalized program is where the most meaningful and lasting change happens, there are several evidence-supported foundations you can begin implementing immediately.
1. Anchor Your Circadian Rhythm at Both Ends
The circadian clock is set primarily by light exposure. Morning light — ideally within 30-60 minutes of waking, outdoors or near a bright window — is one of the most powerful inputs available to anchor cortisol awakening response timing and establish a robust diurnal rhythm. Evening, the inverse is true: reducing bright light (especially blue-spectrum light from screens) in the 60-90 minutes before bed allows melatonin to rise on schedule. These two bookends are foundational and free.
2. Prioritize Dinner Composition for Overnight Glucose Stability
Your last meal has a direct bearing on what your cortisol and blood sugar do at 3am. Aim for dinners that include a meaningful protein source, healthy fats, non-starchy vegetables, and a modest portion of complex carbohydrate — enough to support liver glycogen stores through the night without producing a large glucose spike. If you wake regularly in the early morning hours, consider a small pre-bedtime snack: 1-2 tablespoons of almond butter, a small portion of turkey or cottage cheese, or something similarly protein-and-fat dominant. This is not about adding calories; it is about extending the metabolic buffer that prevents nocturnal hypoglycemia.
3. Move Your Body — But Time It Thoughtfully
Regular physical activity supports HPA axis resilience, improves insulin sensitivity, promotes SCFA production through increased microbiome diversity, and directly enhances slow-wave sleep. The caveat in perimenopause: intense exercise in the late afternoon or evening can elevate cortisol at a time when it should be declining. Morning and midday movement tend to be better timed for women with HPA axis dysregulation. This is not a reason to avoid evening exercise if it’s the only window available — some movement is always better than none — but it is worth experimenting with timing if sleep remains problematic.
4. Feed Your Microbiome for Sleep
Increasing dietary fiber diversity — aiming for 30 or more distinct plant foods per week — is one of the most well-supported interventions for microbiome diversity. This supports SCFA production, butyrate availability, and the downstream gut-brain signaling that promotes deep sleep. Fermented foods (unsweetened yogurt, kefir, kimchi, sauerkraut, miso) provide additional microbiome support. The goal is variety and consistency, not perfection.
5. Take Magnesium Seriously
Magnesium deficiency — which is widespread and dramatically underrecognized in the standard American dietary pattern — directly impairs GABA receptor function, cortisol regulation, and sleep architecture. Forms matter significantly: magnesium oxide (the most common supplement form) is poorly absorbed and primarily acts as a laxative. Magnesium glycinate and magnesium L-threonate are far better choices for nervous system support and sleep. A typical therapeutic dose range is 300-400mg of elemental magnesium (from glycinate or threonate) taken 60-90 minutes before bed. As with all supplementation, discuss with a qualified practitioner, particularly if you have renal considerations.
6. Reconsider Evening Alcohol
Alcohol is one of the most common and most disruptive sleep interventions that women underestimate. A glass of wine in the evening may help you fall asleep faster — alcohol has a mild sedating effect on sleep onset — but it reliably fragments the second half of the night. Alcohol impairs gluconeogenesis (worsening the nocturnal hypoglycemia pattern discussed earlier), suppresses REM sleep, and increases nighttime cortisol reactivity. It is, in functional medicine terms, a direct HPA axis stimulant disguised as a relaxant. For women already dealing with perimenopausal sleep disruption, it is worth an honest experiment: remove evening alcohol for three weeks and observe what happens to your sleep quality in the second half of the night.
Closing: Your Sleep Is a Biological Signal, Not a Personal Failure
I want to leave you with this: if you are not sleeping well in perimenopause, you are not failing at stress management, or self-care, or discipline. You are experiencing the downstream consequences of a biological system under genuine physiological stress — a system that is managing hormonal flux, a recalibrating stress axis, a gut environment that may be compromised, and a nervous system that has been asked to do too much for too long.
That system can be supported. It can recover. It can be asked to do less and given more of what it needs. But that requires understanding what’s actually driving the problem — not just layering supplements on top of unresolved physiology, and not accepting “your labs are normal” as a complete answer.
If this framework resonates — if you recognize yourself in the 3am waking, the wired-but-tired evenings, the sleep that doesn’t restore the way it used to — there are two things I’d like to offer you.
First, my free Functional Medicine Guide to Sleep is available below. It’s the starting point I give to every woman who comes into my practice with sleep as a primary complaint — a practical, evidence-based framework for understanding your sleep biology and beginning the process of working with it rather than against it.
Second, I run a 3-Day Sleep & Stress Recovery Webinar Series several times a year, designed for women who want to go deeper: understanding their specific pattern, getting clarity on what testing would be most useful, and building a personalized roadmap for sleep restoration. Details for the next series are coming soon.
You deserve better than “try to manage your stress.” And the biology says you can do better than that.
— Liz Greenfield, MS, APRN, IFMCP
Download the Free Functional Medicine Guide to Sleep
The starting framework I give every client navigating perimenopausal sleep disruption. Evidence-based, practical, and specific to your biology.
References & Further Reading
The following research literature informed the clinical content of this article.
1. Baker FC, de Zambotti M, Colrain IM, Bei B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:73–95.
2. Genazzani AR, Pluchino N, Luisi S, Luisi M. Estrogen, cognition and a woman’s risk of Alzheimer’s disease. Ann N Y Acad Sci. 2007;1052:106–116. [Referenced for estrogen-REM and serotonin pathway discussion]
3. Bhagya V, Bhattacharya SK, Kumar JR. Hippocampal neurotransmitters in the context of allopregnanolone and GABA-A receptor modulation: implications for sleep and anxiety. J Basic Clin Physiol Pharmacol. 2015. [Referenced for progesterone-allopregnanolone-GABA discussion]
4. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72(1):67–73.
5. Bjorntorp P, Rosmond R. The metabolic syndrome – a neuroendocrine disorder? Br J Nutr. 2000;83(Suppl 1):S49–S57. [Referenced for HPA-cortisol-metabolic interaction]
6. Liang S, Wu X, Hu X, Wang T, Jin F. Recognizing depression from the microbiota–gut–brain axis. Int J Mol Sci. 2018;19(6):1592. [Referenced for gut-brain neurotransmitter discussion]
7. Gao T, Wang Z, Dong Y, et al. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J Pineal Res. 2019;67(1):e12574.
8. Szentirmai É, Millican NS, Massie AR, Kapas L. Butyrate, a metabolite of intestinal bacteria, enhances sleep. Sci Rep. 2019;9(1):7035.
9. Vieira AT, Galvão I, Macia LM, et al. Dietary fiber and the short-chain fatty acid butyrate as mediators of the gut-immune-sleep axis. Front Immunol. 2017. [Referenced for SCFA-sleep architecture discussion]
10. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324–335. [Referenced for estrobolome and estrogen metabolism discussion]
11. Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab. 2010;24(5):731–743. [Referenced for blood sugar and sleep interaction]
12. Roehrs T, Roth T. Sleep, sleepiness, and alcohol use. Alcohol Res Health. 2001;25(2):101–109. [Referenced for alcohol-sleep architecture discussion]
About the Author
Liz Greenfield, MS, APRN, IFMCP, is the founder of Elizabeth Greenfield Functional Wellness, a program-based functional wellness practice specializing in perimenopause, gut health, and longevity science. She works alongside nutritionist and Psychology of Eating Coach Stephanie Doty to deliver structured, lab-guided programs for women navigating the perimenopausal transition and for physicians working to optimize their own healthspan. All programs are delivered via remote wellness consultations nationwide.
Disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The content reflects the clinical perspective and original synthesis of the author. Please consult a qualified healthcare provider for evaluation and management of individual health concerns.